Vice President, Business Development (EMEA / APAC)

Vice President, Business Development (EMEA / APAC)

Apply remote type: Remote | Locations: Spain, Netherlands, Belgium, Poland, United Kingdom

Time type: Full time

Posted on: Posted 3 Days Ago

Job requisition id: R5015

Premier Research is seeking a Vice President, Business Development (EMEA / APAC) to join our team.

You will assist biotech, medtech, and specialty pharma companies in transforming innovative ideas and breakthrough science into new medicines, devices, and diagnostics. Our work is directly connected to saving and improving lives, and we value our team members as our greatest asset.

We are Built for You. We support your growth, provide skills and opportunities to excel, and offer flexibility and balance.

We are Built by You. Your ideas influence our work, and your voice matters.

We are Built with You. As a vital part of our team, you help us deliver essential medical innovations.

Together, we are Built for Biotech. Join us and build your future.

What you'll be doing:

• Attracting, retaining, and developing high-quality employees, including direct line management.
• Leading and supporting Account Managers and Operations through strategic client solutions.
• Managing key accounts directly and engaging with target clients to promote our services.
• Developing plans and strategies for business growth and achieving annual sales goals, including acquiring new business from transactional and strategic accounts, in collaboration with the SVP of BD and the CCO.
• Formulating account strategies and tactics with Account Managers and therapeutic leaders, including generating RFPs and client presentations.

What we are searching for:

• BA / BS with 12-16 years of related experience, or MA with 10-14 years, or MBA / PhD with 8-12 years.
• 7-10 years of experience managing people or processes.
• Proven hands-on management skills, with the ability to lead by example and drive process improvements to enhance sales and efficiency.
• Understanding of Phase I through Phase IV drug development.